Meridian Bioscience, Inc. (NASDAQ:VIVO)
| CAPS Rating |
|
|---|---|
| Open | $17.79 |
| Previous Close | $18.02 |
| Daily Range | $17.45 - $18.04 |
| 52-Week Range | $14.81 - $27.37 |
| Market Cap | $738.51M |
| P/E Ratio | 27.50 |
| Dividend (Yield) | 0.76 (3.70%) |
| Volume | 289,912 |
| Average Daily Volume | 0 |
How do you think VIVO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
VIVO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
VIVO News and Commentary
- Bearish MACD for VIVO - Tale of the Tape – NASDAQ
- How the Wheels Came Off Meridian Bioscience's Bus – The Motley Fool
- Meridian Intros HyperPAGE II Marker - Analyst Blog – NASDAQ
- FDA OKs Meridian's GDH Test - Analyst Blog – NASDAQ
- Is Neogen the Perfect Stock? – The Motley Fool
- Why Meridian Bioscience May Be About to Take Off – The Motley Fool
- Checking the Quality of Neogen's Growth – The Motley Fool
- FDA Clears Meridian illumigene GBS - Analyst Blog – NASDAQ
- Are Meridian Bioscience's Earnings Worse Than They Look? – The Motley Fool
- Meridian Bioscience Earnings Preview – The Motley Fool
- Should You Get Out of Meridian Bioscience Before Next Quarter? – The Motley Fool
- Here's Why Meridian Bioscience's Latest Report Might Worry You – The Motley Fool
- Let's See If Neogen's Growth Is for Real – The Motley Fool
- Why Bio-Rad Laboratories May Be About to Take Off – The Motley Fool
- 8 Healthcare Dividend Stocks Close to 52-Week Low – Blog at The Motley Fool
- Here's How Meridian Bioscience May Be Failing You – The Motley Fool
- Meridian Bioscience Shares Plunged: What You Need to Know – The Motley Fool
- Haemonetics May Be Warning You. Are You Listening? – The Motley Fool
- A Hidden Reason Why the Future Looks Bright for Quidel – The Motley Fool
- Why Quidel's Earnings Are Outstanding – The Motley Fool

RSS Headlines
Fool UK